Table 1.
Prostate Cancer Patients Demographics (N=105)
| Variable | Progression
|
|
|---|---|---|
| No (N = 43) | Yes (N = 62) | |
| Age | 59.62 ± 5.97 | 59.95 ± 6.62 |
|
| ||
| Gleason Score (%) | ||
| <7 | 34 (79.1) | 30 (48.4) |
| ≥7 | 9 (20.9) | 32 (51.6) |
|
| ||
| TNM Stage (%) | ||
| T2a | 22 (51.2) | 36 (58.1) |
| T2b/c | 21 (48.8) | 26 (41.9) |
|
| ||
| Organ Confined (%) | ||
| Yes | 19 (44.2) | 11 (17.7) |
| No | 24 (55.8) | 51 (82.3) |
|
| ||
| Extra Capsular Penetration (%) | ||
| Absent | 32 (74.4) | 30 (48.4) |
| Present | 11 (25.6) | 32 (51.6) |
|
| ||
| Focal Capsular Penetration (%) | ||
| Absent | 22 (51.2) | 13 (21.0) |
| Present | 21 (48.8) | 49 (79.0) |
|
| ||
| Surgical Margin (%) | ||
| Negative | 33 (76.7) | 37 (59.7) |
| Positive | 10 (23.3) | 25 (40.3) |
|
| ||
| Seminal Vesicle (%) | ||
| Negative | 43 (100.0) | 61 (98.4) |
| Positive | 0 (0) | 1 (1.6) |
|
| ||
| Lymph Node (%) | ||
| Negative | 43 (100.0) | 62 (100.0) |
|
| ||
| Her-2/neu (%) | ||
| Negative | 15 (34.9) | 6 (9.7) |
| Positive | 28 (65.1) | 56 (90.3) |
|
| ||
| Nuclear Roundness Variance | 2.60 ± 1.96 | 5.14 ± 4.02 |
|
| ||
| CD31 | 5.81 ± 8.0 | 11.26 ± 18.6 |
|
| ||
| Ki67 | 2.41 ± 5.04 | 4.35 ± 8.54 |
|
| ||
| PCNA | 1.06 ± 1.58 | 1.04 ± 1.26 |
|
| ||
| BCL2 | 8.83 ± 10.92 | 9.92 ± 11.35 |
|
| ||
| Chromogranin A | 23.28 ± 50.3 | 20.88 ± 45.31 |